Skip to main content
. 2013 Jun 10;12:55. doi: 10.1186/1476-4598-12-55

Figure 5.

Figure 5

FKB showed preferential inhibition on 143B cells compared with FHS and bone marrow stem cells. A, FKB treatment exhibited differential effects on 143B OS cells, normal small intestinal epithelial cell (FHS) and bone marrow stem cells. Cells were treated with FKB for 72 h. B, Compared with Adriamycin, FKB showed significantly less bone marrow inhibition effect. C, Representative microphotography, taken at 14 days after treatment of bone marrow stem cell colonies showed the size of a typical colony decreased with a higher concentration of FKB.